Pharmaceutical Manufacturing and Formulation

The contract entails the manufacture of Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% in 10 mL sterile bottles, requiring full compliance with USP standards throughout the entire production process, including sterile formulation, in-process controls, and comprehensive batch testing to ensure purity, potency, and safety. The work must adhere to current Good Manufacturing Practices and maintain rigorous quality assurance protocols to meet pharmaceutical regulatory requirements for ophthalmic use. This is a subcontract under the Department of Defense’s Medical Supply Chain Pharma FSA, with performance location specified as Williamsburg, Virginia, zip code 23185-5830. The solicitation was posted on July 28, 2026, and responses are due by August 3, 2026, utilizing the NAICS code 325412 for pharmaceutical preparation manufacturing. All submissions must be made through the DIBBS platform using the provided solicitation number SPE2DP26T4342, and the contract is intended for a qualified manufacturer capable of delivering a sterile pharmaceutical product to federal supply chain standards.